Recombinant viral vector for gene transfer into lymphoid cells
AssigneeThe Research Foudation for Microbial Diseases of Osaka University
InventorsYasuko Mori, Kenjiro Tadagaki, Masaya Takemoto, Michiaki Takahashi, Koichi Yamanishi
Life of this patent
Estimating the term…
Abstract
A recombinant herpesvirus, a method for producing the recombinant herpesvirus, and a pharmaceutical composition comprising the recombinant herpesvirus, are provided with a method for producing a recombinant herpesvirus using a BAC vector sequence. In addition, a vector comprising a herpesvirus genomic gene and a BAC vector sequence, a cell comprising the vector, and a nucleic acid cassette comprising a fragment, which is capable of homologous recombination with a herpesvirus genome, and a BAC vector sequence, are provided.
Claims1
A method of treatment of infectious disease comprising:
- infecting a T lymphoid cell with a recombinant herpesvirus comprising a BAC vector sequence, wherein the BAC vector sequence is inserted into a non-essential region of a herpesvirus genome, and wherein the non-essential region is a non-essential region of HHV-7 or HHV-6.
Dependencies are inferred from the claim text.